Life Sciences
The startup, which also announced a $3.4 million raise, aims to collect longitudinal patient data for research.
U-Scan, an in-home biomarker analysis platform, sits within the toilet bowl to analyze the user's urine.
The AI-enabled data company will integrate ATCOR and CONNEQT's technology into its platform in early 2023 to monitor maternal health and cardiovascular diseases.
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.
The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.
The investment will support Nectar's growth nationwide, fund clinical trials and help the company open a physical location.
The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.